The inducement plan provides ammunition for hiring key executives, likely in response to activist pressure. Watch for specific grant disclosures under Nasdaq Rule 5635(c)(4) and any further 13D filings indicating board composition changes or strategic demands.
Price Chart
Executive Summary
TuHURA Biosciences adopted a 2026 Inducement Equity Incentive Plan, reserving 5,000,000 shares of common stock for equity awards to new employees as a material inducement to employment, without stockholder approval under Nasdaq Rule 5635(c)(4). This filing follows a recent activist 13D/A filing (August 28, 2026) by James A. Bianco, indicating potential board or management changes are being influenced by activist pressure.
Key Facts
- Board adopted the 2026 Inducement Equity Incentive Plan on September 10, 2026
- 5,000,000 shares of common stock reserved for issuance under the plan
- Plan adopted without stockholder approval under Nasdaq Listing Rule 5635(c)(4)
- Awards limited to new employees as material inducement to employment
- Activist James A. Bianco filed a Schedule 13D/A on August 28, 2026 (19 days prior)
Financial Impact
5,000,000 shares reserved for future equity grants; potential dilution of approximately 5-10% of current outstanding shares depending on current share count (not disclosed in filing). No immediate cash impact.
Risk Factors
- Potential dilution of up to 5,000,000 shares for new hires
- Activist involvement may escalate if management changes are not satisfactory
- No specific grants disclosed yet — uncertainty about who will receive awards
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-393206 |
| Document: hura-ex10_2.htm | 0001193125-26-393206 |
| Document: hura-20260910.htm | 0001193125-26-393206 |
| Document: 0001193125-26-393206-index-headers.html | 0001193125-26-393206 |
| Document: 0001193125-26-393206-index.html | 0001193125-26-393206 |
| Document: 0001193125-26-393206.txt | 0001193125-26-393206 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 9d ago | 8-K | $1.78 | awaiting T+60 | — | $2.03 (+14.04%) |
Sep 24, 2026 4w ago | 8-K | $2.10 | awaiting T+60 | — | $2.03 (−3.33%) |
Sep 17, 2026 5w ago | 8-K | $2.10 | awaiting T+60 | — | $2.03 (−3.33%) |
Sep 16, 2026 5w ago | 8-K | $2.09 | awaiting T+60 | — | $2.03 (−2.87%) |
Sep 4, 2026 7w ago | 8-K | $2.12 | awaiting T+60 | — | $2.03 (−4.25%) |
Aug 19, 2026 9w ago | 8-K | $2.22 | awaiting T+60 | — | $2.03 (−8.56%) |
Aug 14, 2026 10w ago | 8-K | $2.47 | awaiting T+60 | — | $2.03 (−17.81%) |
Aug 14, 2026 10w ago | Press Release | $2.47 | awaiting T+60 | — | $2.03 (−17.81%) |
Aug 13, 2026 10w ago | 8-K | $2.47 | awaiting T+60 | — | $2.03 (−17.81%) |
Jul 29, 2026 12w ago | 8-K | $2.17 $2.18 | ▲ +0.46% | ▼ −2.00% | $2.03 (−6.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers